Cross-Border Investigations in the
Pharma Industry

Macaluso/Moreillon/Lombardini/Garbarski (eds.), Développments récents en droit pénal de l' entreprise V, Bern 2024, 63 ff. Book chapter The publication explores the complex landscape of cross-border investigations in the pharmaceutical industry. It provides an overview of typical topics in pharma investigations, including bribery and corruption, antitrust and competition law, regulatory compliance, ESG, IP, trade secrets and data privacy. As an example, it then focuses in more detail on investigations of transnational allegations within multinational pharmaceutical companies in Switzerland. This includes addressing typical investigation triggers, the duty to investigate, the investigating methodology, the clashes between jurisdictions, the duty to self-disclose, and the resolution of allegations with Swiss authorities.